MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) saw a significant growth in short interest in June. As of June 30th, there was short interest totaling 341,209 shares, a growth of 382.8% from the June 15th total of 70,680 shares. Based on an average trading volume of 197,013 shares, the short-interest ratio is currently 1.7 days.
MediPharm Labs Stock Up 0.2%
Shares of MEDIF traded up $0.00 during midday trading on Friday, reaching $0.05. 708 shares of the stock were exchanged, compared to its average volume of 82,302. The business’s 50-day moving average price is $0.06 and its 200 day moving average price is $0.05. MediPharm Labs has a twelve month low of $0.04 and a twelve month high of $0.08.
About MediPharm Labs
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
See Also
- Five stocks we like better than MediPharm Labs
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
